Opportunistic Infections: Treatment and Prophylaxis: Infectious Disease
Autor Vassil St. Georgieven Limba Engleză Hardback – 27 feb 2003
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 787.63 lei 43-57 zile | |
Humana Press Inc. – 19 noi 2010 | 787.63 lei 43-57 zile | |
Hardback (1) | 1105.97 lei 43-57 zile | |
Humana Press Inc. – 27 feb 2003 | 1105.97 lei 43-57 zile |
Din seria Infectious Disease
- 5% Preț: 646.40 lei
- 5% Preț: 1411.04 lei
- 18% Preț: 711.32 lei
- 5% Preț: 1406.21 lei
- 5% Preț: 787.63 lei
- 5% Preț: 683.00 lei
- 5% Preț: 1091.99 lei
- 5% Preț: 1075.79 lei
- 5% Preț: 1390.92 lei
- 5% Preț: 1082.79 lei
- 5% Preț: 777.56 lei
- 5% Preț: 1027.12 lei
- 5% Preț: 1364.19 lei
- 18% Preț: 1259.07 lei
- 5% Preț: 2038.58 lei
- 18% Preț: 929.05 lei
- 5% Preț: 1390.41 lei
- 5% Preț: 1095.19 lei
- 5% Preț: 1407.64 lei
- 5% Preț: 1102.75 lei
- 5% Preț: 1098.80 lei
- 5% Preț: 710.88 lei
- 18% Preț: 1232.26 lei
- 5% Preț: 1321.68 lei
- 5% Preț: 1403.52 lei
- 5% Preț: 725.03 lei
- 5% Preț: 700.61 lei
Preț: 1105.97 lei
Preț vechi: 1164.18 lei
-5% Nou
Puncte Express: 1659
Preț estimativ în valută:
211.66€ • 220.50$ • 175.98£
211.66€ • 220.50$ • 175.98£
Carte tipărită la comandă
Livrare economică 10-24 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781588290090
ISBN-10: 1588290093
Pagini: 545
Ilustrații: XX, 545 p.
Dimensiuni: 178 x 254 x 31 mm
Greutate: 1.18 kg
Ediția:2003
Editura: Humana Press Inc.
Colecția Humana
Seria Infectious Disease
Locul publicării:Totowa, NJ, United States
ISBN-10: 1588290093
Pagini: 545
Ilustrații: XX, 545 p.
Dimensiuni: 178 x 254 x 31 mm
Greutate: 1.18 kg
Ediția:2003
Editura: Humana Press Inc.
Colecția Humana
Seria Infectious Disease
Locul publicării:Totowa, NJ, United States
Public țintă
Professional/practitionerCuprins
I. Viral Infections.- 1 Cytomegalovirus.- 2 Varicella-Zoster Virus (Herpes Zoster) Infections.- 3 Herpes Simplex Virus.- II. Bacterial Infections.- 4 Nocardia SPP..- 5 Oerskovia SSP..- 6 Rhodococcus Equi.- 7 Tsukamurella SSP..- 8 Mycobacterium Tuberculosis.- 9 Mycobacterium Bovis.- 10 Nontuberculous Mycobacterial Infections.- 11 Listeria Monocytogenes.- 12 Gastrointestinal Infections in the Immunocompromised Host.- III. Parasitic Infections.- 13 Cryptosporidium SPP..- 14 Isospora SPP..- 15 Toxoplasma Condii.- 16 Microsporidia.- 17 Strongyloides Stercoralis.- 18 Cyclospora SPP..- IV. Fungal Infections.- 19 Cryptococcus Neoformans.- 20 Candida Albicans.- 21 Emerging Candida SPP. Infections.- 22 Trichosporon Beigelii.- 23 Rhodotorula SPP..- 24 Hansenula (Pichia) SPP..- 25 Dematiaceous Fungal Infections: Phaeohyphomycosis and Chromoblastomycosis.- 26 Hyalohyphomycosis.- 27 Histoplasma SPP..- 28 African Histoplasmosis.- 29 Blastomyces Dermatitidis.- 30 Aspergillus SPP..- 31 Coccidioides Immitis.- 32 Paracoccidioides Brasiliensis.- 33 Penicillium Marneffei.- 34 Zygomycosis (Mucormycosis, Phycomycosis).- 35 Pneumocystis Carinii.
Textul de pe ultima copertă
The complex problems of opportunistic infections in patients suffering from an underlying immunodeficiency is a significant medical issue and calls for a concise, yet comprehensive, resource to present the essential information that clinicians require to provide effective medical care. In Opportunistic Infections: Treatment and Prophylaxis, Vassil St. Georgiev surveys the current status of all the major bacterial, viral, parasitic, and fungal infections affecting the immunocompromised population, as well as the anti-infective agents available to treat and prevent them. The author covers individual infections caused not only by well-known etiologic agents, but also by new and emerging species often closely related taxonomically to a major disease-producing microorganism and until recently not considered a human pathogen (e.g., Candida spp. and nontuberculous mycobacteria). The information presented includes data from large well-planned clinical trials, as well as reports of cases involving individuals and small numbers of patients. The latter highlight therapeutic possibilities that may otherwise go unnoticed in clinical practice or in drug research and development. Numerous examples are given of particular treatment regimens for opportunistic infections based on underlying immunologic deficiencies.
Comprehensive and up-to-date, Opportunistic Infections: Treatment and Prophylaxis organizes the wealth of information found in the medical and scientific literature and illuminates those areas of drug development and treatment that, though still not well understood, are crucial to effective patient management, infection prevention, and the development of new therapeutic modalities against infectious diseases in immunocompromised patients.
Comprehensive and up-to-date, Opportunistic Infections: Treatment and Prophylaxis organizes the wealth of information found in the medical and scientific literature and illuminates those areas of drug development and treatment that, though still not well understood, are crucial to effective patient management, infection prevention, and the development of new therapeutic modalities against infectious diseases in immunocompromised patients.
Caracteristici
Includes supplementary material: sn.pub/extras